Endocrine Abstracts

JOINT259

Background: Amidst the pandemic in 2021, HelloType1.com was developed by Action4Diabetes (A4D), a non-governmental organization collaborating with local healthcare professionals in Southeast Asia, as an innovative digital educational platform for Type 1 diabetes (T1D) in regional local languages. HelloType1 was launched in Cambodia, Vietnam, Thailand, and Malaysia from 2021 to 2023, with Memorandums of Understandings (MOUs) signed between A4D and each country. HelloType1 Facebook page was also created for each country in their local languages for sign-posting to the HelloType1 website.

Aims: This study aims to investigate the usability and internet data analytics of HelloType1 within each participating country from 2021-2023

Methods: Data analytics utilised Google Analytics (GA4) with tracking data from the website hellotype1.com, and Facebook analytics were analysed from the Facebook online metrics

Results: The total number of users of the HelloType1.com digital platform grew by 382% between 2021 and 2022 with the launch of the programme in Vietnam (March 2022) and in Thailand (November 2022) and by 47% between 2022 and 2023 with the launch of the programme in Malaysia (May 2023). In 2023, 20% of the total users of the programme are Facebook followers and 80% are website users. The average pages per sessions increased from 2 pages to more than 3 pages in 2023 showing the interest of the user to browse for more content. More than half of the traffic of HelloType1.com originated from search engines (56% in 2023). On the Facebook sites, the organic page reach has increased by 120% between 2022 and 2023 with an increased engagement rate from 8% to 14% in 2023 which demonstrate the high interest from the followers and their willingness to interact and share the HelloType1 Facebook content with their community.

Conclusions: These internet analytics offer valuable insights into the delivery of an innovative diabetes educational resource in local languages, particularly in low-middle income countries with limited resources. Future plans are underway to use the platform to create a local community support and a peer-to-peer networks with online workshops for patients and caregivers, where the community can ask their questions via cha forums on the Facebook site that can be moderated by patients and caregivers. In addition, we hope that the programmes will be supported by local governments for example in Malaysia, the Hellotype1 in the local language is endorsed by the Ministry of Health.